Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Christopher D. Ruark
Observed name:
Christopher Ruark
Institution:
Procter & Gamble (United States)
Observed institutions:
Henry M. Jackson Foundation,
United States Air Force Research Laboratory,
Wright State University,
Wright-Patterson Air Force Base,
The Hamner Institutes for Health Sciences,
711th Human Performance Wing,
Wright Laboratory,
Procter & Gamble (United States)
show all 8
ORCID:
0000-0003-1032-5696
Observed ORCID:
0000-0003-1032-5696
OpenAlex ID:
A5013309414
Predicting Passive and Active Tissue:Plasma Partition Coefficients: Interindividual and Interspecies Variability
2014
·
Christopher D. Ruark
, C. Eric Hack
, et al.
·
Journal of Pharmaceutical Sciences
·
57
Quantitative bias analysis for epidemiological associations of perfluoroalkyl substance serum concentrations and early onset of menopause
2016
·
Christopher D. Ruark
, Gina Song
, et al.
·
Environment International
·
54
Quantitative structure–activity relationships for organophosphates binding to acetylcholinesterase
2012
·
Christopher D. Ruark
, C. Eric Hack
, et al.
·
Archives of Toxicology
·
39
Development of a Physiologically Based Model to Describe the Pharmacokinetics of Methylphenidate in Juvenile and Adult Humans and Nonhuman Primates
2014
·
Xiaoxia Yang
, Suzanne M. Morris
, et al.
·
PLoS ONE
·
35
PDF
A physiologically based pharmacokinetic model for the oxime TMB-4: simulation of rodent and human data
2013
·
Teresa R. Sterner
, Christopher D. Ruark
, et al.
·
Archives of Toxicology
·
27
Quantitative bias analysis of a reported association between perfluoroalkyl substances (PFAS) and endometriosis: The influence of oral contraceptive use
2017
·
Gerard Ngueta
, Matthew P. Longnecker
, et al.
·
Environment International
·
18
Quantitative Structure–Activity Relationships for Organophosphates Binding to Trypsin and Chymotrypsin
2010
·
Christopher D. Ruark
, C. Eric Hack
, et al.
·
Journal of Toxicology and Environmental Health
·
18
PDF
High-Throughput Screening for Positive Allosteric Modulators Identified Potential Therapeutics against Acetylcholinesterase Inhibition
2015
·
Richard R. Chapleau
, Craig A. McElroy
, et al.
·
SLAS DISCOVERY
·
9
Physiologically based pharmacokinetic model: distribution processes
2020
·
Christopher Ruark
·
Elsevier eBooks
·
5
CHAPTER 8. Modeling Organophosphorus Chemical Warfare Nerve Agents: A Physiologically Based Pharmacokinetic–Pharmacodynamic (PBPK-PD) Model of VX
2016
·
Tammie R. Covington
, Lucille A. Lumley
, et al.
·
Issues in toxicology
·
5
Organophosphorus Inhibition and Characterization of Recombinant Guinea Pig Acetylcholinesterase
2015
·
Christopher Ruark
, Richard Chapleau
, et al.
·
Protein and Peptide Letters
·
3
Collaborative Core Research Program for Chemical-Biological Warfare Defense
2015
·
Jeffery M. Gearhart
, Christopher D. Ruark
, et al.
The Guinea Pig Model For Organophosphate Toxicology and Therapeutic Development
2015
·
Christopher D. Ruark
·
CORE Scholar (Wright State University)
Quantitative Structure-Activity Relationships for Organophosphate Enzyme Inhibition
2012
·
Christopher D. Ruark
, C. Eric Hack
, et al.
·
ACS symposium series
Quantitative Structure-Activity Relationships for Organophosphate Enzyme Inhibition (Briefing Charts)
2011
·
Christopher D. Ruark
, Kyung Yu
Show more works
View as search
Works count:
16
Citation count:
270
H-index:
8
I10-index:
7
Year
Topic
Type